Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Takeda Pharmaceutical (NYSE:TAK) Releases FY 2025 Earnings Guidance

Summary by marketbeat.com
Takeda Pharmaceutical (NYSE:TAK) updated its FY 2025 earnings guidance. The company provided EPS guidance of 3.160-3.160 for the period. The company also issued revenue guidance of $29.4 billionillion-$29.4 billionillion, compared to the consensus estimate of $28.5 billionillion.

1 Articles

marketbeat.commarketbeat.com
Center

Takeda Pharmaceutical (NYSE:TAK) Releases FY 2025 Earnings Guidance

Takeda Pharmaceutical (NYSE:TAK) updated its FY 2025 earnings guidance. The company provided EPS guidance of 3.160-3.160 for the period. The company also issued revenue guidance of $29.4 billionillion-$29.4 billionillion, compared to the consensus estimate of $28.5 billionillion.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Friday, January 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Osaka icon

Osaka

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal